Association of the British Pharmaceutical Industry
 |
|
| Abbreviation | APBI |
|---|---|
| Formation | 1891 |
| Legal status | Industry trade group |
| Purpose | Pharmaceutical industry trade organisation |
| Location |
|
|
Region served
|
UK |
|
Membership
|
Pharmaceutical manufacturers |
|
Chief Executive
|
Mike Thompson |
| Website | ABPI |
The Association of the British Pharmaceutical Industry (ABPI) is the trade association for over 120 companies in the UK producing prescription medicines for humans. This is the British equivalent of America's PhRMA, however the member companies research, develop, manufacture and supply 80% of branded medicines prescribed through the National Health Service.
The organisation was founded in London in 1891. It was originally known as the Drug Club. A rival institution to represent wholesalers, the Northern Wholesale Druggists' Association, was formed in 1902; it lasted until 1966.
A board of management of members oversee the ABPI. The Board is made up of individuals who are elected by members to represent the industry; and up to five people who are co-opted by the Board. Elections commence every January for elected seats to ensure that the Board is fully representative and has access to the broadest range of skills and expertise possible.
As of 2016[update], the Association's RM&I Director was Dr. Virginia Acha.
John Kearney became President of the ABPI on 24 April 2015.
ABPI's head office is in London and there are three regional offices in Cardiff, Belfast and Edinburgh.
Members of the ABPI fall into three categories:
ABPI membership is not open to individuals, only companies.
The ABPI represents the views of the pharmaceutical industry to government and decision makers in the UK.
The organisation has six departments:
The medical and innovation department oversees complimentary resources for schools in UK to promote links between school science subjects and their applications in industrial research. The department also runs a careers website. The association also sponsors booklets on a range of conditions, aimed at patients, carers and healthcare professionals.
In addition, the association has lobbied for the UK government to adopt the European Union directive on biotechnology research.
The Code of Practice of the ABPI covers the promotion of medicines for prescribing to health professionals and administrative staff as well as the provision of information to the public about prescription only medicines in the UK and is administered by the Prescription Medicines Code of Practice Authority (PMCPA). All ABPI member companies are obliged to comply with both the spirit and letter of the Code.
...
Wikipedia